FDA Inspection 1261182 — Catalent U.K. Swindon Zydis Limited

Catalent U.K. Swindon Zydis Limited — FEI 3003812585

The FDA completed an inspection of Catalent U.K. Swindon Zydis Limited on June 15, 2023 in Swindon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Swindon (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)